Maternal and Neonatal Complications of Methamphetamine Use during Pregnancy
Table 1
Comparison of characteristic features between the study group and control group.
Characteristic
Study (n = 103)
Control (n = 103)
OR
95% CI
value
Age (years)
29.2 ± 6.1
27.7 ± 6.4
—
—
0.104
<20
4 (3.9)
9 (8.7)
0.42
0.12–1.41
0.251
20–34
81 (78.6)
78 (75.7)
1.18
0.61–2.26
0.739
≥35
18 (17.5)
16 (15.5)
1.15
0.55–2.40
0.851
Thai ethnicity
101 (98)
95 (92.2)
4.25
0.08–20.53
0.52
Multiparity
85 (82.5)
51 (49.5)
4.81
2.54–9.11
<0.001
PPW (kg)
53.8 ± 11.3
56.1 ± 13.5
—
—
0.191
BMI (kg/m2)
21.2 ± 3.9
22.3 ± 4.9
—
—
0.097
ANC visit
2.1 ± 2.8
7.7 ± 3.6
—
—
<0.001
No ANC
48 (46.6)
5 (4.7)
17.10
6.42–45.50
<0.001
Alcohol
13 (12.6)
0 (0)
2.14
1.84–2.49
<0.001
Smoker
40 (38.8)
1 (1.0)
2.55
2.09–3.12
<0.001
STD
Syphilis
1 (0.97)
0 (0)
—
—
1.000
Hepatitis B
0 (0)
0 (0)
—
—
—
HIV
5 (4.9)
0 (0)
—
—
0.059
∗n (%), PPW: prepregnancy weight, BMI: body mass index, ANC: antenatal care, No ANC: unattended antenatal care, Alcohol: alcoholic drinker, STD: sexually transmitted disease, HIV: human immunodeficiency virus.
